The startup using AI to help rare disease families develop custom treatments
Nome uses AI and drug-development expertise to help rare disease families turn genetic diagnoses into potential paths toward treatment.
Nome uses AI and drug-development expertise to help rare disease families turn genetic diagnoses into potential paths toward treatment. This story matters for Finance & Markets readers tracking option. Reported by cnbc.com. Read the full original at the source link below.
Originally reported by cnbc.com. OptionNews curates and briefs the finance & markets stories that matter. Our editorial policy →